               SEQUENCE LISTING

<110> Jiangyin USUN Pharmaceutical Co., Ltd.

<120> NEW CONJUGATES

<130> USUCZ/P76627PC

<140> PCT/CN2021/081361
<141> 2021-03-17

<160> 127

<170> BiSSAP 1.3.6

<210> 1
<211> 10
<212> PRT
<213> Unknown


<220> 
<223> Mefp-1 decapeptide

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa represents hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 1
Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys 
1               5                   10  

<210> 2
<211> 10
<212> PRT
<213> Unknown


<220> 
<223> Mefp-1 decapeptide analogue

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 2
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys 
1               5                   10  

<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> VARIANT
<222> 1,2,3
<223> Wherein Xaa is absent or is are selected from one or more of the
      group serine, lysine, alanine, and 3,4-dihydroxyphenylalanine

<220> 
<221> VARIANT
<222> 2
<223> Wherein where Xaa at position 1 is absent, Xaa is optionally
      N-terminally modified with a 3,4-diydrocinnamic acid group, or is
      not so modified

<220> 
<221> VARIANT
<222> 3
<223> Wherein where Xaa at positions 1 and 2 are absent, Xaa is
      optionally N-terminally modified with a 3,4-diydrocinnamic acid
      group, or is not so modified

<220> 
<221> VARIANT
<222> 4
<223> Wherein where Xaa at positions 1, 2, and 3 is absent, Lys is
      optionally N-terminally modified with a 3,4-diydrocinnamic acid
      group, or is not so modified

<220> 
<221> VARIANT
<222> 5
<223> Wherein Xaa is selected from proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 7
<223> Wherein Xaa is absent or is selected from tyrosine or
      3,4-dihydroxyphenylalanine

<220> 
<221> VARIANT
<222> 8
<223> Wherein Xaa is selected from serine, proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 9
<223> Wherein Xaa is selected from the group lysine, alanine, proline,
      hydroxyproline, dihydroxyproline, threonine,
      3,4-dihydroxyphenylalanine, and tyrosine

<220> 
<221> VARIANT
<222> 10..13
<223> Wherein Xaa is absent or is selected from the group lysine,
      alanine, proline, hydroxyproline, dihydroxyproline, threonine,
      3,4-dihydroxyphenylalanine, and tyrosine

<400> 3
Xaa Xaa Xaa Lys Xaa Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10              

<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 4
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys Xaa 
1               5                   10      

<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 5
Ala Lys Pro Ser Tyr Pro Pro Thr Xaa Lys 
1               5                   10  

<210> 6
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<400> 6
Ala Lys Pro Ser Tyr Pro Thr Tyr Pro Lys 
1               5                   10  

<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 7
Ala Lys Pro Ser Tyr Pro Thr Xaa Pro Lys 
1               5                   10  

<210> 8
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is hydroxyproline

<400> 8
Ala Lys Pro Ser Tyr Pro Xaa Thr Tyr Lys 
1               5                   10  

<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 9
Ala Lys Pro Ser Tyr Pro Xaa Thr Xaa Lys 
1               5                   10  

<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is dihydroxyproline

<400> 10
Ala Lys Pro Ser Tyr Xaa Pro Thr Tyr Lys 
1               5                   10  

<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 11
Ala Lys Pro Ser Tyr Xaa Pro Thr Xaa Lys 
1               5                   10  

<210> 12
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 12
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 13
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 13
Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 14
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 14
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys Xaa 
1               5                   10      

<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 15
Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys Xaa 
1               5                   10      

<210> 16
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 16
Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys Xaa 
1               5                   10      

<210> 17
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 17
Lys Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa 
1               5                   10  

<210> 18
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4,7,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 18
Lys Ala Lys Xaa Ser Tyr Xaa Xaa Thr Xaa 
1               5                   10  

<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4,7,8
<223> Wherein Xaa is hydroxyproline

<400> 19
Lys Ala Lys Xaa Ser Tyr Xaa Xaa Thr Tyr 
1               5                   10  

<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 20
Lys Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr 
1               5                   10  

<210> 21
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 21
Xaa Lys Pro Ser Tyr Xaa Thr Ala Xaa Lys 
1               5                   10  

<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 22
Xaa Lys Pro Ser Tyr Xaa Xaa Thr Ala Lys 
1               5                   10  

<210> 23
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,10
<223> Wherein Xaa is hydroxyproline

<400> 23
Xaa Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10      

<210> 24
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 24
Xaa Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys 
1               5                   10      

<210> 25
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,10
<223> Wherein Xaa is hydroxyproline

<400> 25
Xaa Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10      

<210> 26
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 26
Xaa Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys 
1               5                   10      

<210> 27
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Lys is N-terminally modified with 3,4-Dihydrocinnamic
      acid

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,6
<223> Wherein Xaa is hydroxyproline

<400> 27
Lys Pro Ser Tyr Xaa Xaa Thr Ala Lys 
1               5                   

<210> 28
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with 3,4-Dihydrocinnamic
      acid

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 28
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 29
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 29
Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 30
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 30
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys 
1               5                   10  

<210> 31
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 31
Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys 
1               5                   10  

<210> 32
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Lys is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<400> 32
Lys Pro Ser Tyr Xaa Thr Ala Xaa Lys 
1               5                   

<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4,7,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 33
Lys Ala Lys Xaa Ser Xaa Xaa Xaa Thr Xaa 
1               5                   10  

<210> 34
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 34
Lys Ala Lys Pro Ser Xaa Xaa Xaa Thr Xaa 
1               5                   10  

<210> 35
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 35
Ala Lys Pro Ser Xaa Pro Pro Thr Tyr Lys 
1               5                   10  

<210> 36
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 36
Ala Lys Pro Ser Xaa Pro Pro Thr Xaa Lys 
1               5                   10  

<210> 37
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 37
Ala Lys Pro Ser Xaa Pro Thr Tyr Pro Lys 
1               5                   10  

<210> 38
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 38
Ala Lys Pro Ser Xaa Pro Thr Xaa Pro Lys 
1               5                   10  

<210> 39
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is hydroxyproline

<400> 39
Ala Lys Pro Ser Xaa Pro Xaa Thr Tyr Lys 
1               5                   10  

<210> 40
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is hydroxyproline

<400> 40
Ala Lys Pro Ser Xaa Pro Xaa Thr Xaa Lys 
1               5                   10  

<210> 41
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is hydroxyproline

<400> 41
Ala Lys Pro Ser Xaa Xaa Pro Thr Tyr Lys 
1               5                   10  

<210> 42
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is hydroxyproline

<400> 42
Ala Lys Pro Ser Xaa Xaa Pro Thr Xaa Lys 
1               5                   10  

<210> 43
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 43
Ala Lys Pro Ser Xaa Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 44
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 44
Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 45
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 45
Lys Ala Lys Pro Ser Xaa Xaa Xaa Thr Tyr 
1               5                   10  

<210> 46
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4,7,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 46
Lys Ala Lys Xaa Ser Xaa Xaa Xaa Thr Tyr 
1               5                   10  

<210> 47
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 47
Ala Lys Pro Ser Xaa Xaa Xaa Thr Tyr Lys Xaa 
1               5                   10      

<210> 48
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,9,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 48
Ala Lys Pro Ser Xaa Xaa Xaa Thr Xaa Lys Xaa 
1               5                   10      

<210> 49
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 49
Ala Lys Pro Ser Xaa Xaa Thr Tyr Xaa Lys Xaa 
1               5                   10      

<210> 50
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8,11
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 50
Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa Lys Xaa 
1               5                   10      

<210> 51
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 51
Xaa Lys Pro Ser Xaa Xaa Thr Ala Xaa Lys 
1               5                   10  

<210> 52
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 52
Xaa Lys Pro Ser Xaa Xaa Xaa Thr Ala Lys 
1               5                   10  

<210> 53
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,6,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,10
<223> Wherein Xaa is hydroxyproline

<400> 53
Xaa Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10      

<210> 54
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,6
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 54
Xaa Ala Lys Pro Ser Xaa Xaa Xaa Thr Tyr Lys 
1               5                   10      

<210> 55
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,6,10
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,8
<223> Wherein Xaa is hydroxyproline

<400> 55
Xaa Ala Lys Pro Ser Xaa Xaa Xaa Thr Xaa Lys 
1               5                   10      

<210> 56
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 56
Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 57
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 57
Ala Lys Pro Ser Xaa Xaa Xaa Thr Xaa Lys 
1               5                   10  

<210> 58
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Lys is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<400> 58
Lys Pro Ser Xaa Xaa Thr Ala Xaa Lys 
1               5                   

<210> 59
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Lys is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 4
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 5,6
<223> Wherein Xaa is hydroxyproline

<400> 59
Lys Pro Ser Xaa Xaa Xaa Thr Ala Lys 
1               5                   

<210> 60
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,6
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 7,10
<223> Wherein Xaa is hydroxyproline

<400> 60
Xaa Ala Lys Pro Ser Xaa Xaa Thr Tyr Xaa Lys 
1               5                   10      

<210> 61
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 61
Ala Lys Pro Ser Xaa Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 62
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 62
Ala Lys Pro Ser Xaa Xaa Xaa Thr Tyr Lys 
1               5                   10  

<210> 63
<211> 12
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is optionally N-terminally modified with a
      3,4-Dihydrocinnamic acid group

<220> 
<223> Peptide component

<220> 
<221> VARIANT
<222> 1,2
<223> Wherein Xaa is absent or is selcted from serine, lysine, alanine,
      or 3,4-dihydroxyphenylalanine

<220> 
<221> VARIANT
<222> 4
<223> Wherein Xaa is selected from proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 6
<223> Wherein Xaa is absent or is selected from tyrosine or
      3,4-dihydroxyphenylalanine

<220> 
<221> VARIANT
<222> 7
<223> Wherein Xaa is serine, proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 8,9,10
<223> Wherein Xaa is absent or is selected from the group: lysine,
      alanine, proline, hydroxyproline, dihydroxyproline, threonine,
      3,4-dihydroxyphenylalanine, and tyrosine

<220> 
<221> VARIANT
<222> 11
<223> Wherein Xaa is selected from proline, hydroxyproline,
      dihydroxyproline, threonine, 3,4-dihydroxyphenylalanine, and
      tyrosine

<220> 
<221> VARIANT
<222> 12
<223> Wherein Xaa is absent or is lysine

<400> 63
Xaa Xaa Lys Xaa Ser Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10          

<210> 64
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 64
Lys Pro Ser Tyr Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 65
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,6,9
<223> Wherein Xaa is hydroxyproline

<400> 65
Lys Pro Ser Tyr Xaa Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 66
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 66
Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   

<210> 67
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<400> 67
Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   

<210> 68
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 68
Ser Lys Pro Ser Tyr Xaa Xaa Thr Xaa Lys 
1               5                   10  

<210> 69
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 69
Ser Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys 
1               5                   10  

<210> 70
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 70
Ser Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 71
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 71
Ser Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 72
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 72
Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10      

<210> 73
<211> 11
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7,10
<223> Wherein Xaa is hydroxyproline

<400> 73
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Xaa Lys 
1               5                   10      

<210> 74
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 74
Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 75
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 75
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 76
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 76
Lys Pro Ser Tyr Xaa Xaa Thr Xaa Xaa 
1               5                   

<210> 77
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,6,9
<223> Wherein Xaa is hydroxyproline

<400> 77
Lys Pro Ser Tyr Xaa Xaa Thr Tyr Xaa 
1               5                   

<210> 78
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 7
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 78
Lys Pro Ser Tyr Xaa Thr Xaa Xaa 
1               5               

<210> 79
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is hydroxyproline

<400> 79
Lys Pro Ser Tyr Xaa Thr Tyr Xaa 
1               5               

<210> 80
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 80
Ser Lys Pro Ser Tyr Xaa Xaa Thr Tyr 
1               5                   

<210> 81
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 81
Ser Lys Pro Ser Tyr Xaa Thr Xaa Xaa 
1               5                   

<210> 82
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 82
Ser Lys Pro Ser Tyr Xaa Thr Tyr Xaa 
1               5                   

<210> 83
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 83
Ala Lys Pro Ser Tyr Xaa Xaa Thr Xaa Xaa 
1               5                   10  

<210> 84
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7,10
<223> Wherein Xaa is hydroxyproline

<400> 84
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Xaa 
1               5                   10  

<210> 85
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 85
Ala Lys Pro Ser Tyr Xaa Thr Xaa Xaa 
1               5                   

<210> 86
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 86
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa 
1               5                   

<210> 87
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 9
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 87
Ser Lys Pro Ser Tyr Xaa Xaa Thr Xaa 
1               5                   

<210> 88
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 88
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr Lys 
1               5                   10  

<210> 89
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 89
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 90
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 90
Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 91
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<400> 91
Ala Lys Pro Ser Pro Thr Tyr Pro Lys 
1               5                   

<210> 92
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,9
<223> Wherein Xaa is hydroxyproline

<400> 92
Ala Lys Xaa Ser Tyr Xaa Thr Tyr Xaa Lys 
1               5                   10  

<210> 93
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 93
Ala Lys Xaa Ser Xaa Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 94
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 94
Ala Lys Xaa Ser Tyr Xaa Thr Xaa Xaa Lys 
1               5                   10  

<210> 95
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,7
<223> Wherein Xaa is hydroxyproline

<400> 95
Ala Lys Pro Ser Tyr Xaa Xaa Thr Tyr 
1               5                   

<210> 96
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Ala is N-terminally modified with a 3,4-Dihydrocinnamic
      acid group

<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 96
Ala Lys Pro Ser Tyr Xaa Thr Tyr Xaa 
1               5                   

<210> 97
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 97
Ala Lys Pro Ser Xaa Xaa Thr Xaa Xaa 
1               5                   

<210> 98
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<400> 98
Ala Lys Pro Ser Pro Thr Tyr Pro 
1               5               

<210> 99
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,9
<223> Wherein Xaa is hydroxyproline

<400> 99
Ala Lys Xaa Ser Tyr Xaa Thr Tyr Xaa 
1               5                   

<210> 100
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 100
Ala Lys Xaa Ser Xaa Xaa Thr Xaa Xaa 
1               5                   

<210> 101
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,9
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 101
Ala Lys Xaa Ser Tyr Xaa Thr Xaa Xaa 
1               5                   

<210> 102
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is hydroxyproline

<400> 102
Ala Lys Pro Ser Xaa Xaa Thr Tyr Lys Xaa 
1               5                   10  

<210> 103
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 103
Ala Lys Xaa Ser Xaa Xaa Thr Tyr Lys Xaa 
1               5                   10  

<210> 104
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is hydroxyproline

<400> 104
Ala Lys Pro Ser Tyr Xaa Thr Tyr Lys Xaa 
1               5                   10  

<210> 105
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,10
<223> Wherein Xaa is hydroxyproline

<400> 105
Ala Lys Xaa Ser Tyr Xaa Thr Tyr Lys Xaa 
1               5                   10  

<210> 106
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 106
Ala Lys Pro Ser Tyr Xaa Thr Xaa Lys Xaa 
1               5                   10  

<210> 107
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 107
Ala Lys Xaa Ser Tyr Xaa Thr Xaa Lys Xaa 
1               5                   10  

<210> 108
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 6,10
<223> Wherein Xaa is hydroxyproline

<400> 108
Ala Lys Pro Ser Xaa Xaa Thr Xaa Lys Xaa 
1               5                   10  

<210> 109
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 3,6,10
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 5,8
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 109
Ala Lys Xaa Ser Xaa Xaa Thr Xaa Lys Xaa 
1               5                   10  

<210> 110
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> VARIANT
<222> 2
<223> Wherein Xaa is selected from proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 4
<223> Wherein Xaa is absent or is selected from tyrosine or
      3,4-dihydroxyphenylalanine

<220> 
<221> VARIANT
<222> 5
<223> Wherein Xaa is selected from serine, proline, hydroxyproline, or
      dihydroxyproline

<220> 
<221> VARIANT
<222> 6
<223> Wherein Xaa is selected from proline, hydroxyproline,
      dihydroxyproline, threonine, 3,4-dihydroxyphenylalanine, or
      tyrosine

<400> 110
Lys Xaa Ser Xaa Xaa Xaa Lys 
1               5           

<210> 111
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 6
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 111
Lys Pro Ser Tyr Xaa Xaa Lys 
1               5           

<210> 112
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Peptide component

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is hydroxyproline

<400> 112
Lys Pro Ser Tyr Xaa Tyr Lys 
1               5           

<210> 113
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> VARIANT
<222> 2,3
<223> Wherein Xaa is selected from proline, alanine, hydroxyproline,
      threonine, 3,4-dihydroxyphenylalanine, or tyrosine

<400> 113
Pro Xaa Xaa Lys 
1               

<210> 114
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is hydroxyproline

<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> VARIANT
<222> 2,3
<223> Wherein Xaa is selected from proline, alanine, hydroxyproline,
      threonine, 3,4-dihydroxyphenylalanine, or tyrosine

<400> 114
Xaa Xaa Xaa Lys 
1               

<210> 115
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> VARIANT
<222> 2,3
<223> Wherein Xaa is selected from proline, alanine, hydroxyproline,
      threonine, 3,4-dihydroxyphenylalanine, or tyrosine

<400> 115
Thr Xaa Xaa Lys 
1               

<210> 116
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 116
Pro Thr Xaa Lys 
1               

<210> 117
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<400> 117
Pro Thr Tyr Lys 
1               

<210> 118
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<400> 118
Thr Tyr Pro Lys 
1               

<210> 119
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 2
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 119
Thr Xaa Pro Lys 
1               

<210> 120
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is hydroxyproline

<220> 
<223> Amino acid sequence defined by Y

<400> 120
Xaa Thr Tyr Lys 
1               

<210> 121
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is hydroxyproline

<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 121
Xaa Thr Xaa Lys 
1               

<210> 122
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1
<223> Wherein Xaa is hydroxyproline

<220> 
<223> Amino acid sequence defined by Y

<400> 122
Xaa Thr Ala Lys 
1               

<210> 123
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is hydroxyproline

<400> 123
Thr Tyr Xaa Lys 
1               

<210> 124
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 2
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is hydroxyproline

<400> 124
Thr Xaa Xaa Lys 
1               

<210> 125
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is hydroxyproline

<400> 125
Thr Ala Xaa Lys 
1               

<210> 126
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<221> SITE
<222> 1,4
<223> Wherein Xaa is hydroxyproline

<220> 
<223> Amino acid sequence defined by Y

<400> 126
Xaa Thr Tyr Xaa Lys 
1               5   

<210> 127
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Amino acid sequence defined by Y

<220> 
<221> SITE
<222> 3
<223> Wherein Xaa is hydroxyproline

<220> 
<221> SITE
<222> 5
<223> Wherein Xaa is 3,4-dihydroxyphenylalanine

<400> 127
Thr Tyr Xaa Lys Xaa 
1               5   

